Scoping review of pharmaceutical service provided by community pharmacists for patients with chronic diseases in China
- VernacularTitle:我国社区药师对慢性疾病患者药学服务的范围综述
- Author:
Yuanhui HU
1
;
Guolin LI
1
;
Chang FENG
2
;
Yuyao PEI
1
;
Yufen ZHENG
1
Author Information
1. School of Basic Medicine and Clinical Pharmacy，China Pharmaceutical University，Nanjing 210009，China
2. School of Pharmacy，University of Waterloo，Ontario N2L 3G1，Canada
- Publication Type:Journal Article
- Keywords:
community pharmacist;
community pharmacy
- From:
China Pharmacy
2024;35(20):2559-2564
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To summarize and analyze the profile of the implementation of pharmaceutical service by community pharmacists for patients with chronic diseases in China. METHODS Literature was searched from CNKI， Wanfang database， PubMed （Medline）， Embase， and Scopus to collect studies about community pharmacists providing pharmaceutical services for patients with chronic diseases. The ways and contents of the implementation of pharmaceutical services for chronic diseases by community pharmacists were summarized descriptively. RESULTS A total of 75 studies were included， involving 49 trial studies and 26 cross-sectional studies. The study sites were mainly located in the developed regions of China， and the types of disease involved in the studies were mainly diabetes mellitus （n＝30） and hypertension （n＝28）； most studies used the following indexes to evaluate pharmaceutical services， such as changes in disease symptoms and related indicators（n＝35）， improvement of patient compliance（n＝34）， and the occurrence of adverse drug reactions （irrational drug use） （n＝25）. The pharmaceutical service provided by community pharmacists included medication education （84.0%）， monitoring and follow-up （64.0%）， and identifying and solving medication-related problems （58.7%）. Thirty-eight studies mentioned that pharmaceutical services were achieved through teamwork， 16 of which mentioned healthcare alliances. A few studies investigated stratified healthcare systems （n＝15） and internet-based pharmaceutical services （n＝10）. CONCLUSIONS In China， pharmaceutical services provided by community pharmacies for patients with chronic diseases are still mainly confined to economically developed areas， and the scope of services is limited to a few diseases and basic pharmaceutical practices. In the future， the implementation of precise pharmaceutical services for different diseases and patients’ disease status， the establishment of medical alliances， and the development of internet-based pharmaceutical services should become the focus of pharmaceutical services.
